A new study released earlier this month on May 2 in the research journal Pain suggests that an injection of cannabis terpenes is “roughly equal” to the number of pain reduction markers from an injection of morphine.
Researchers sought out to see how cannabis can potentially treat chronic pain. “A question that we’ve been very interested in is could terpenes be used to manage chronic pain?” said John Streicher, PhD, who is the lead author of the study. “What we found is that terpenes are really good at relieving a specific type of chronic pain with side effects that are low and manageable.”
While both CBD and THC have been found to be beneficial in treating chronic pain, researchers explained that the effects are moderate, and “can come with unwanted psychoactive side effects.” Terpenes are a path around the use of psychoactive substances, which “offer an alternative path to pain relief without adverse side effects.”
For the purpose of this study, researchers examined five different terpenes: alpha-humulene, beta-caryophyllene, beta-pinene, geraniol, and linalool. Researchers utilized a mouse model focused on neuropathic pain, which is a well-known condition that stems from nerve damage caused by chemotherapy medications.
Each terpene was tested on its own and the results were compared with morphine as well. All five terpenes showed significant pain reduction “near to or above the peak effect of morphine” individually, and even more powerful effects on pain when combined. “That was really striking to us, but just because something relieves pain doesn’t necessarily mean it’s going to be a good therapy,” Streicher said.
The negative effects of using opioids include an activation of the reward system in the brain, which can lead to an increased tolerance to the effects over time, and addiction as well. But terpenes don’t lead to these same effects. “We looked at other aspects of the terpenes, such as does this cause reward? Is this going to be addictive? Is it going to make you feel awful?” said Streicher. “What we found was yes, terpenes do relieve pain, and they also have a pretty good side effect profile.”
Researchers also examined the method of consumption with terpenes, including injection, oral dosing, and inhalation. When orally administered or inhaled, the effects were “significantly reduced or absent.” “A lot of people vape or smoke terpenes as part of cannabis extracts that are available commercially in states where cannabis use is legal,” said Streicher. “We were surprised to find that the inhalation route didn’t have an impact in this study, because there are a lot of at least anecdotal reports saying that you can get the effects of terpenes whether taken orally or inhaled. Part of the confounding factor is that terpenes smell quite nice and it’s hard to disguise that aroma, so people could be kind of having the psychosomatic placebo-style effect.”
Previously, Streicher and his team published their findings from a similar study back in July 2021. At the time, their results showed promising evidence regarding terpenes being used for pain relief, especially when studying the benefits of the entourage effect. Although their hypothesis was to examine how cannabinoids affected pain, they were ultimately surprised by how powerful the entourage effect actually was. “It was unexpected, in a way,” Streicher said in 2021. “It was our initial hypothesis, but we didn’t necessarily expect terpenes, these simple compounds that are found in multiple plants, to produce cannabinoid-like effects.”
Looking toward the future, Streicher plans to utilize these results in his next research endeavor. In a press release, he explained that his next hypothesis will explore if terpenes can block the body’s reward system and also still provide the same pain treatment as seen in the most recent results. “This brings up the idea that you could have a combination therapy, an opioid with a high level of terpene, that could actually make the pain relief better while blocking the addiction potential of opioids. That’s what we are looking at now,” said Streicher.
Over time, other terpene studies have revealed how they can serve as a treatment option for certain conditions.
A study from 2020 published in Molecules defined terpenes in detail to “describe sources of cannabis terpenes and to explain the biosynthesis and diversity of terpene profiles in different cannabis chemovars.” Their results showed that terpenes and cannabinoids used together show evidence of the entourage effect.
In February 2023, one study from researchers at the University of New Mexico found that patient relief was best experienced with higher terpene levels.
In October 2023, a study performed by researchers at Abstrax Tech and published in the American Chemical Society’s journal, Omega, showed that the importance of terpenes is “overstated” when it comes to defining the differences between cultivars. “This discrepancy suggests that while these classifications may be helpful for chemotaxonomic purposes, they lack the chemical information necessary to differentiate these varieties from an aroma perspective,” the study stated.
Dedicated to my imaginary friends Hoppy Soppy and Monster Scooter.
My therapist Peter-Tuesdays-At-Noon (and sometimes Peter-Fridays-At-Nine) said I need a healthier work/life balance. He suggested taking Sundays off, and doing whatever I want.
I asked him, “Could I write about it?”
He said, “That’s work.”
I said, “No, it’s fun.”
He said, “If you must.”
So, with P.T.A.N.’s blessing every Sunday I’m making it my mission to get lifted and live more!
TL;DR – Overall I’d give this Sunday an 8.4/10.
This Sunday I got high, drank coffee, ate a bagel, saw the movie IF with a friend, walked home, got high, ate pizza, watched NHL highlights and sneaker videos on Youtube, jacked off, went to bed.
If you’d like a more in-depth look into my self-care Sunday let’s get into it!
(Editor’s Note: There will not be an in-depth look into jacking off. We aren’t sure why he tried to fight us on this.)
THE KEY TO A BALANCED BREAKFAST IS AN EDIBLE
I usually start my mornings by checking my phone, and being called a cuck on Instagram — but not on Sundays! On Sunday, I began my morning with a 5mg gummy followed by checking a group text asking friends who can see a movie.
The group text was off to a rocky start.
So, I decided to check back later, and go get some breakfast. Maybe by then Steve Bannon will respond.
Walking into an Alfred coffee shop, the edible started to make my bones settle. I ordered my standard fare: a large iced black coffee. The barista asked if I wanted any milk, but I declined saying, “No thanks.” Low-key milk gives me diarrhea, but my intuition told me she didn’t want to hear that truth.
After getting my coffee I turned the corner towards the Yeastie Boys bagel truck. I think the Beastie Boys are massively overrated [Editor’s Note: he’s wrong about this.], but Yeastie Boys are not. I grabbed an everything bagel with a jalapeno cheddar cream cheese schmear. They hooked the schmear up! I offered them an edible as thanks, but they said no so I ate theirs.
Great way to start a Sunday!
ONCE WE GOT TO THE MOVIE THINGS GOT OUT OF CONTROL
My good buddy Gabe texted me back to see IF at 4:30 at The Grove AMC Theater.
Gabe is the person who isn’t me.
We coordinated seating, and I locked the tickets in.
Highlighted in yellow for accuracy.
Movie theater seating is crucial for a stoner. I prefer a back corner seat like L1 so I can hit a vape throughout the movie. However, this was opening weekend, so call me Liam Neeson because my seat was Taken. Instead, I took an aisle seat with a clear pathway to the bathroom to go vape in a stall if the movie stunk.
This is where it goes south. As an AMC A-Lister I can see three movies a week for free, and I get to stand in a special VIP concession line that cuts in front of the peasants waiting for their snacks in the basic bitch regular line. A-List costs $25 a month, and is worth it in every way except one. They check every A-Lister’s ID when they scan your ticket. They claim it’s to make sure people aren’t sneaking into movies for free on someone else’s account. It makes me so mad. I don’t pay all this money every month, essentially keeping the movie industry in business single-handedly, to be treated like riff raff. You don’t check the plebs’ ID’s to make sure they’re who they say they are too.
What’s next? Making me wear a scarlet A on my Fear of God t-shirt to be allowed in? Fix it, AMC CEO Adam Aron. He follows me on Instagram so he will see this.
We also saw a table claiming to help your child be discovered in Hollywood, but after seeing Quiet on the Set this is giving big pedo/groomer vibes so I’m gonna move on.
Absolutely not.
IF ROCKS!
IF is rated PG. It was the perfect movie for a theater packed with families, and two very stoned dudes. We all had a blast. It’s two hours of childlike escapism filled with imaginary friends, silly jokes, vibrant montages, and swirling music. The perfect stoner cinematic experience — and not to brag but I figured out the twist in the kids movie before it was revealed.
I only had three complaints.
1) Every review of it is written by adults, and they trash it. Hey Dumdum, it’s not for you. Let kids write reviews for kid movies. See it in a theater filled with children like we did, and you’ll hear them laughing, cheering, gasping in wonderment, and their parents finding a moment of peace.
2) Parents, pick up your trash. The theater was a disaster when the lights came up. Popcorn cartons, soda cups, and candy wrappers everywhere. Teach your kids to pick up after themselves so the people who work at AMC don’t have to do it. It’s gross, and you’re better than that.
3) I took this pic when someone clapped after the Nicole Kidman commercial. Buddy, we’re past that. Its moment is up. Also, Nicole’s sitting in an empty theater for the whole thing. That’s not giving “I love movies” like you think it is.
WRAP IT UP LIKE A BLIZZIE
Sundaze rock. I’m all about taking the day off to get lifted and live life. I’m not sure what I’ll do next Sunday, but I hope Kelly Anne Conway is free.
Mike Glazer is a comedian who loves weed. He’d love it if you followed him onInstagramandYoutube.
Connecticut made legal weed regulatory history on Monday as Erin Gorman Kirk, the nation’s first cannabis ombudsperson, began work as the state’s official advocate for medical marijuana patients.
Gorman Kirk, an attorney, entrepreneur and experienced consumer advocate, is a medical marijuana patient who has been instrumental in drafting cannabis and hemp policy in Connecticut and several other states. Her personal experience with utilizing cannabis, for both herself and other patients she has helped, inspired Gorman Kirk to apply for the new position of cannabis ombudsperson, a position created by the Connecticut General Assembly last year.
The state created the Office of the Cannabis Ombudsman to monitor the palliative use of cannabis and the medical marijuana industry and to act on behalf of medicinal cannabis patients and caregivers. The cannabis ombudsperson operates with administrative support from the state Office of the Healthcare Advocate.
Gorman Kirk said that as Connecticut’s new cannabis ombudsperson, she intends to be a “vigilant guardian of patient interests, making sure that every decision and action taken by producers aligns with the highest standards of care and compassion.”
“We will not only monitor but actively engage with all stakeholders to improve the palliative marijuana market, making Connecticut a model state for patient advocacy in the cannabis sector,” she told CTInsider.
Gorman Kirk was hired from a pool of more than 800 applicants for the position. While she has been actively involved in developing cannabis policy, Gorman Kirk noted that her primary focus has been advocating for patients and consumers, not business interests.
“I am not a lobbyist. Never have been. I’m an advocate,” Gorman Kirk told online news source CTNewsJunkie in a recent interview. “I do probably 750 to 1,000 hours of pro-bono a year. I’m the only lawyer in the country who did every application on a pro-bono basis for social equity candidates. That’s how much I care about people and patients.”
Gorman Kirk noted that she is aware of the potential risks consumers and patients face when they use cannabis. At one time, she noticed adverse effects after using cannabis that had been grown in Connecticut. After she stopped using the products, her symptoms improved.
“Someone said to me, oh, there’s a lot of mold in it. So I started to do some research,” she said. “I went to some of the people that I help with recommendations and caregiving, one of whom is a 95-year-old Parkinson’s patient, who’s a Korean War veteran, and asked them how they were feeling. Everyone was feeling poorly. And I became concerned when I realized these mold levels and or remediation levels, of which we have not been apprised, something was going on, that was different from what you get at a farm.”
Connecticut Has Legal Medical Marijuana and Recreational Pot
Connecticut legalized the medical use of marijuana in 2012, followed by the legalization of adult-use cannabis in 2021. With recreational weed now available, the number of patients registered in Connecticut’s medical marijuana program has begun to decline. In January 2023, nearly 49,000 patients were registered to use medical weed. By April of this year, the number of patients had dropped to just over 40,000.
Gorman Kirk says that Connectiuct’s medical marijuana program has also seen other effects following the legalization of recreational marijuana.
“There was an absolute dearth of product availability but lacking consistency,” she said. “Patients could not get the same product week after week. So, we learned that people were driving to Massachusetts to get their medicine, which concerns me deeply as an attorney. Unfortunately, as absurd as it is, you cannot take your medicine with you on vacation. And so that presented a problem and it was also a loss of revenue, and it was clear that the medical-marijuana patients had been left behind as far as I was concerned.”
All regulated cannabis in Connecticut must be tested for safety and purity to protect the health of consumers and medical marijuana patients, many of whom have compromised immune systems or other serious medical challenges. A lack of uniform testing standards, however, means that cannabis that passes testing in one state may be deemed unsafe in a state with more stringent standards. Gorman Kirk says she would like to see industry-wide standards developed in the interest of public safety.
“There’s a company called ASTM,” she said. “And they are trying to create standards and I think standards would be great in other states. I think Missouri, for example, won’t let you even use hybrid or Sativa or Indica. They are demanding you utilize terpenes. So, I would love to see universal standards brought in.”
Lou Rinaldi, a medical cannabis patient advocate who testified before the state legislature on the bill that created the Office of the Cannabis Ombudsman, praised the launch of the new patient advocacy position in Connecticut.
“It has taken far too long, but medical cannabis patients in Connecticut finally have a champion to give them a voice in their own program,” Rinaldi told CTInsider. “I am thrilled to see Erin Gorman Kirk in this role and I look forward to what will undoubtedly be a lengthy list of impactful accomplishments geared toward improving patient outcomes.”
Psychedelics policy reform advocates in California are calling for a ballot initiative to legalize certain drugs including psilocybin and MDMA after legislative attempts at change failed to cross the finish line two years in a row.
Last year, California lawmakers approved a bill from Democratic state Senator Scott Wiener that would have allowed regulated access to certain psychedelic substances. However, California Governor Gavin Newsom vetoed the legislation in October, calling on the legislature to instead pass regulations to govern the therapeutic use of psychedelic drugs.
Wiener responded earlier this year with a new bill he co-authored with several Senate colleagues to regulate the therapeutic use of psychedelics. But that measure is now apparently dead for the legislative session after a Senate committee failed to advance the bill earlier this month. After two unsuccessful bids at psychedelics reform in the legislature, advocates for change including Wiener are considering a ballot initiative to allow voters to decide the issue.
“We are not giving up, whether that means introducing a new bill or ballot measure, this issue is not going away,” Wiener told KQED public television news after the bill’s demise. “We know these substances are helping people turn their lives around.”
Wiener said that the psychedelics legalization ballot measure would likely appear on the ballot for the 2026 general election. He added that he may also return to the legislature with another bill, noting that both avenues of change can be pursued simultaneously.
Psychedelics advocates are considering whether a potential ballot measure should be broader than the bill to regulate the therapeutic use of the drugs sought by Newsom and are looking to the governor to take a leadership position on the issue.
“We hope Governor Newsom puts his action where his mouth is. He’s the one that suggested this bill. Now is the time for him to also be a leader in this space and help us find a path forward,” former Army Ranger Jesse Gould told KQED.
In 2017, Gould launched the Heroic Heart Project to help fellow military veterans gain access to psychedelics-assisted therapeutic services. Many vets seek out such services in foreign countries where regulations are more permissive to treat post-traumatic stress disorder or other mental health challenges. Others make use of unregulated therapists in the United States. Advocates for change say all paths to reform are still under consideration.
“All options are on the table. A ballot measure certainly is,” Gould said. “It’s clear that if the politicians won’t speak for their people then we need to bring this to the people. And this is a popular subject for voters in California.”
Support for Psychedelics Reform Growing
Support for psychedelics policy reform is growing nationwide, with cities including Seattle, San Francisco, Denver and Washington, D.C. passing ordinances to effectively decriminalize possession of some psychedelic drugs. Public opinion surveys show strong support for reform, including a 2023 U.C. Berkeley poll showing that 61% of American registered voters support legalizing the therapeutic use of psychedelics.
“Californians will continue to seek out psychedelics for all sorts of reasons, including to help alleviate mental health challenges like PTSD, depression and anxiety. Many will do so without guided support and use psychedelics on their own, which increases risks,” said Jared Moffat, Campaign Director for the Alliance for Safer Use of Psychedelics, in a statement. “We’re not backing down, and will keep pushing to ensure facilitated access to psychedelics becomes a reality in California and that Californians are protected from harm.”
The calls for a psychedelics legalization ballot measure come less than two weeks after Wiener’s most recent legislation, Senate Bill 1012, was rejected by a legislative committee in the upper chamber of the California state legislature. Despite the failure, the San Francisco Democrat vowed to renew the fight. But future legislation could be a hard sell with state leaders facing shortfalls in the upcoming budget.
“We’ve been working for four years to legalize access to psychedelics in California, to bring these substances out of the shadows and into the sunlight, and to improve safety and education around their use,” Wiener said in a May 16 statement after the Senate Appropriations Committee declined to advance the bill. “We’re in a terrible budget year, where all bills with significant costs are at risk. Nevertheless, it’s disappointing for this bill not to move forward. Psychedelics have massive promise in helping people heal and get their lives back on track. It makes enormous sense for California to lead in creating regulated access under the supervision of a licensed professional. I’m highly committed to this issue, and we’ll continue to work on expanding access to psychedelics.”
As more states continue to legalize adult-use cannabis, we’re witnessing a growing trend surrounding ownership of cannabis businesses — namely that Native American tribes are investing in cannabis with tribal-owned stores becoming increasingly more common in recent years.
According to data published in MJBizDaily, the number of tribally owned retailers has grown by roughly 25% since January 2023. As of May 2024, there are 57 tribally owned dispensaries, both medical and adult-use, throughout nine states.
With legal adult-use cannabis becoming more commonplace throughout the country, tribes are entering the industry to diversify their economies and boost revenue.
Though legal cannabis also carries unique benefits for tribes, as a way to assert their sovereignty and seize the first-to-market advantage in newly legal states, as explained by guest columnist Matthew Klas, a senior associate with Minneapolis-based national consulting firm KlasRobinson Q.E.D. specializing in economic development on tribal lands.
A Closer Look at Tribal-Owned Cannabusinesses
There are 574 Native American tribes recognized by the U.S. government, with roughly 350 falling in the lower 48 states. Sovereign nations may have their own laws that differ from state laws, sometimes more restrictive — like cannabis sales and use bans even within states that have enacted recreational reform — or sometimes offering more leniency than state law.
While many of the stores are on tribal lands, not all are.
Tribes are currently operating businesses in nine states: California, Michigan, Minnesota, Nevada, New Mexico, New York, North Carolina, South Dakota and Washington.
The data found that the average size of tribal cannabis stores is about 4,300 square feet, ranging from stores with less than 1,000 square feet to complexes spanning more than 10,000.
Washington state has the most tribal retailers and the most tribes operating shops, at 23 stores operated by 18 tribes. Nevada is second, with 10 tribal stores owned by eight different tribes. Most of these tribally owned shops are located within markets with legal recreational cannabis, though there are exceptions. For example, there are two tribally owned dispensaries in South Dakota and one in North Carolina that currently offer medical cannabis exclusively.
The data does not include businesses owned by individual tribal members, rather than a tribal government.
Newly Approved Markets, New Opportunities
We can look at Minnesota to see how tribal business owners are able to get a jumpstart on a budding industry, as lawmakers in the state legalized adult-use cannabis last year but have yet to begin licensing retail establishments.
It’s unlikely that the marketplace will open until at least 2025, leaving a gap between legalization and the opening of the regulated market. However, tribal-owned dispensaries are helping to bridge that gap as two dispensaries owned by the Red Lake Nation and White Earth Nation are currently serving adult-use customers with plans to open additional facilities in the future.
According to Minnesota’s recreational cannabis law, the governor can negotiate compacts with state tribes if they seek to take advantage of cannabis sales, but it also “acknowledges the sovereign right of Minnesota Tribal governments” to regulate their cannabis industries even without a compact. Red Lake and other tribes can also operate dispensaries outside of reservations through compacts negotiated with the governor’s administration.
“We see this as a resource not only to reduce harm, but to also bring in resources to help our people recover,” said Red Lake Nation Tribal Secretary Sam Strong.
The Mille Lacs Band of Ojibwe is also constructing a 50,000 square foot cannabis cultivation facility near Minneapolis, which is larger than any state-licensed grow operations, that will focus on seed-to-sale operations and could be a crucial part of the state’s recreational industry upon full launch.
Similarly, New York has witnessed numerous delays in the launch of its recreational cannabis market, but three tribally owned stores have opened in the state since 2023.
With Minnesota’s specific laws designed to leave room for tribal sovereignty, Klas says that the Minnesota market will be “particularly interesting” to watch in the future, adding that, “Minnesota could see some of the fastest growth of tribal cannabis businesses in the United States.”
Maybe you’ve been hearing about THCA Snow Caps aka THCA Snowballs, which are slowly becoming a very in-demand product on the hemp market, as more and more customers are gravitating toward high-potency flower products. THCA snowcaps, also known as snowcaps, are named after their frosty appearance, and they are extremely potent, making them great for those who crave an extra-strong THCA kick.
If you’re curious to know what THCA snowcaps can offer to hemp enthusiasts, stick around folks, because we’ll be explaining what they are, how they’re made, and how to grab the highest-quality snowballs that are out there today.
And if you want to try THCA Snow Caps use our code HIGHTIMES25 for 25% off while being treated to fast and free shipping here.
THCA Snow Caps: What’s all The Hype About?
First up, we want to shed light on exactly what THCA Snowcaps are. We’re all familiar with THCA flower, which is hemp-derived flower buds that are bred carefully to produce a high concentration of THCA. THCA, of course, is tetrahydrocannabinolic acid, aka delta 9’s raw form, which turns into delta 9 when it’s exposed to a specific temperature, which can be achieved through smoking, vaping, or cooking/baking with the flower buds.
THCA flower is hugely popular because it’s chemically identical to weed, while being protected under federal law. THCA snowballs take the concept to a new level, by coating each high-THCA flower bud in THCA diamond dust. THCA diamonds are purified/
THCA cannabinoid, which naturally takes on a crystalline form. Odorless, colorless, and flavorless, THCA diamonds are pure THCA, meaning that their potency is high, and they, like the flower, actually provide delta 9 THC once heated.
THCA diamond dust is the result of crushing the diamonds into a fine power. By coating each bud in this powder, you get a flower bud that has an outstanding THCA concentration – up to 80%, in fact, while traditional flower buds rarely exceed 30%.
Regular vs. Exotic THCA Snow Caps
THCA snow caps are used interchangeably with THCA flower buds. You can smoke them, vape them, bake with them, or what have you, with no difference between how they’re utilized vs. standard flower. And, they’re cultivated just like regular flower, since again, the only difference is that THCA snowcaps are rolled in diamond dust after the curing process is complete.
With that being said, THCA Snow Caps, like THCA flower, can vary in terms of how they’re cultivated. All THCA flower comes from industrial hemp, which can be grown indoors, outdoors, or in a greenhouse, with all kinds of different techniques used to ensure the best outcome of the flower buds themselves.
Exotic THCA snowcaps come from exotic THCA flower buds, and this distinctive classification speaks to the exceptional quality and high THCA percentage that customers are in for. In order to be considered exotic, THCA flower must have the following qualities:
Must be grown in small batches, with special attention paid to each individual plant.
Must come in strains that have prestigious genetics.
Must have a uniquely fragrant aroma and satisfying flavor.
The buds must be aesthetically pleasing, and hand-trimmed.
THCA snowcaps, therefore, are going to be a step above the rest, as this is the highest caliber of quality that you can find. It should be pointed out that most exotic THCA flower is grown indoors, as it’s easier to control the outcome of the buds through manipulation of light, temperature, and so on, all of which play a major role in the development of the desirable cannabinoids and terpenes in the plant.
Who Would Benefit Most from THCA Snowballs?
Again, THCA Snowballs are a high-potency product, which means that they’re best for someone who already has a good THC tolerance. Because THCA converts into delta 9 THC when flower is consumed, the high you can get from using snowballs is pretty intense. For those who find that regular flower is too mild for them, that’s a good thing.
Also, remember, THCA snowcaps offer tremendous value. They’re so powerful that a little goes a long way, basically stretching out your supply so you can go longer between having to reup.
Are THCA Snowballs the Same as THCA Moonrocks?
You will see THCA snowcaps confused for THCA moonrocks pretty frequently, but these are ultimately two different products. THCA moonrocks are THCA flower buds infused with THCA distillate and covered in kief, which is a full-spectrum powder that naturally falls off of the trichomes of the buds. This is different from THCA snowcaps, which are more potent, as they’re covered in a thick layer of pure THCA diamond dust.
Buy THCA Snow Caps Online at Bloomz!
THCA Snow Caps are the next big thing on the hemp market, and Bloomz has you covered with outstanding, high-quality and well-crafted THCA Snowballs, combining the most exceptional flower with pure THCA diamonds for max potency and max satisfaction.
Bloomz has over 4,000 five-star customer reviews, over 100,000 loyal customers, fast and free shipping, 24/7 customer service, and best of all the strongest THCA Snow Caps on the market with flower above 30% potency. It does not get much better than that!
You will be able to enjoy boutique-level and indoor-grown THCA snowballs, available in 3.5g and 7g options, which are made using organically homegrown buds that’re already high in tetrahydrocannabinolic acid, rolled in Bloomz signature 99% pure THCA diamond dust. The extravagant potency of these snowcaps means that you’re in for a high that’s out of this world.
Best of all you get to explore all 4 strains while finding satisfaction on a whole new level – 2 “standard” and 2 “exotic” strains.
THCA Snowball Indoor Premium Strains
THCA Snowcaps are Indoor High Percentage THCA Flower covered in potent and pure THCA Isolate. Ideal for connoisseurs seeking the highest quality and intensity, these THCA snowcaps deliver a powerful experience in every puff. You can truly elevate your sessions with the purest, most potent THCA SnowCaps on the market.
MAC
MAC is a 50/50 hybrid short for Miracle Alien Cookies, with roughly 24% THCA. Its carefree high is legendary, offering a feeling of relief in the mind and body, as you stay calm yet uplifted throughout the experience. It’s a dank strain with pungent notes of diesel, citrus, and earthiness.
Pineapple OG
A cross between Pineapple Express and OG Kush, Pineapple OG is a superstar of a cultivar, with about 26% THCA, and a 70% sativa orientation. It’s a sociable strain that can make you feel chatty, euphoric, and like all is right in the world, and can relax the body without sedating you.
THCA Snowball Gold Line Premium Strains
This is Exotic THCA Flower used with these snowcaps in order to create the strongest and best batches of farm-grown THCA Flower around. Combined with pure THCA Isolate, this Snowcaps THCA Flower is the top choice on the hemp marketplace.
Sour Diesel
Sour Diesel is a 90% sativa-dominant hybrid that’s legendary, with its powerful notes of diesel and sour lemons, and its ability to offer up a major boost in energy, chattiness, and creativity.
Mendo Purps
Mendo Purps is a 60/40 sativa-dominant hybrid with roughly 22% THC, known for its ability to give you fits of giggles, acting as the perfect social strain for when you want to partake with your friends.
Bloomz THCA Flower Offers High Potency for Maximum Satisfaction!
Overall, if you’re looking to get as high as possible off of THCA Snowcaps , then you have found your new favorite flower brand: Bloomz. Here, you can explore 2 distinctive product lines, both offering high levels of THCA that you know and love.
Head on over to Bloomz and check out their selection, keeping in mind that their Gold Line Snowcaps delivers the highest THCA levels you will discover on the hemp marketplace today and don’t forget to use the code HIGHTIMES25 for 25% off while being treated to fast shipping so that you can take advantage of this THCA Snow Caps.
Martha’s Vineyard is an island off the coast of Massachusetts that’s known for its 23 miles of scenic hills and beaches. It’s a popular destination for summer vacationers enjoying the quaint Victorian architecture, as of July 2021, it had one medical cannabis dispensary (Fine Fettle Dispensary) which until recently was also the only cannabis cultivator on the island, in addition to one adult-use only dispensary (Island Time) which opened in August 2021.
The cost of living is high in Martha’s Vineyard, and for business owners, it’s expensive to transport goods from the mainland across the Vineyard Sound (aka the stretch of ocean that sits between Cape Cod, Massachusetts and Martha’s Vineyard). For cannabis businesses, it’s also federally illegal to have cannabis products delivered from the mainland.
Recently, the owner of Island Time, Geoff Rose, filed a lawsuit against the Massachusetts Cannabis Control Commission (CCC) regarding a rule that bans him from transporting cannabis by boat from the mainland. “For more than 11 years, my efforts have centered on providing safe and responsible cannabis to local residents and visitors alike,” Rose explained to the Vineyard Gazette. “I’m hoping that the court will mandate the commission take immediate action to allow us to transport the product from the mainland.” He added that the rule puts a burden on him as a business owner, since he can only sell cannabis that he cultivates on the island.
This rule was put in place because of state and federal regulations about cannabis being moved across water or through airspace. Rose’s lawsuit claims that Vineyard Sound is still within the state’s jurisdiction.
Earlier in May, the other dispensary and sole owner of the island’s only cannabis production license, Fine Fettle Dispensary, announced that it would be shutting down operations. “Very sadly, we have had to make the decision to slow down and then ultimately shut down operations on the Vineyard,” Fine Fettle Dispensary president Benjamin Zachs said to the Vineyard Gazette. Up until now, Island Time obtained all of its cannabis products from Fine Fettle Dispensary.
To bypass this new change, Rose inquired with the CCC about ordering cannabis from the mainland, but the CCC rejected the idea, stating the limitations of violating federal law. In March, Rose had cannabis delivered by boat anyway, and the products were delivered on a Steamship Authority ferry, which is run by the U.S. Coast Guard and falls under federal authority.
The unnamed supplier that Rose worked with later received a warning. He was told not to sell the products delivered via ferry, but that order was later lifted, and Rose was able to sell out of all of the products.
Last week, Rose officially closed his dispensary and told customers that he is unable to receive any new product. “We will reopen when we are able to source products from the mainland,” Rose wrote. “I am hopeful for a resolution soon that will result in more products, choices, and value for you, our valued customer.”
Through the lawsuit, Rose is calling for the Suffolk County Superior Court to grant an injunction so that he can have cannabis delivered to the island. “[Island Time] is being starved to death by the Commission’s arbitrary, unreasonable and inconsistent policy against transporting marijuana and marijuana products over state territorial waters,” Rose explained, warning that his employees will seek other jobs if his business is closed for two weeks or more.
On May 9, the CCC met to discuss the situation and potential courses of action. Not only would the lack of delivery cause Island Time to close permanently, but it would also leave medical cannabis patients living on the island without any access to medicine. “If we do nothing, you are going to have 234 patients with no medical access on the Island. That’s the reality of it,” said commissioner Kimberly Roy.
Additionally, local resident Sally Rizzo filed an affidavit with the supreme court as well. “If I have no retail source of marijuana for my medical needs, my quality of life will suffer significantly,” she wrote. “I am unwilling—and should not be compelled—to risk purchasing untested marijuana from the illicit black market or purchasing marijuana from the Massachusetts mainland and transporting it to my home via the Steamship Authority to treat my documented medical condition.”
The commission itself didn’t provide any comment to Vineyard Gazette due to ongoing litigation, and only verified what the current law allows or doesn’t allow. “At this time, transportation of marijuana from the Commonwealth mainland to the island counties is not one of those accommodations,” the CCC stated. “To the extent permitted by law, the Commission has been discussing what may be possible in terms of extending additional accommodations to these licensees and will be scheduling a public meeting on Martha’s Vineyard within the next month to continue the conversation.”
However, there are examples of products being delivered in some other states, such as New York, where ferry delivery over water is still counted as “ground transport.” Similar rules are in place for the delivery of cannabis from mainland California to Catalina Island.
On the industrial outskirts of Oakland, California, tucked among the timeworn facades of warehouses and workshops, there’s a building entrance so nondescript it defies capture by photography—not only would you never notice it if you walked right past it, you wouldn’t even be able to see it if you were looking directly at it. Security is a paramount concern for cannabis businesses operating in “The Town,” and thanks to a serendipitous quirk of forced perspective and pre-war architecture, would-be bandits would have an easier time robbing the Hogwarts Express. This is ideal for a business trying to prevent unwelcome visitors, but much less so for a visiting journalist with a faulty sense of direction and a penchant for getting stoned before big interviews.
In addition to being monstrously difficult to locate, once you step inside the building housing the corporate headquarters for James Loud Genetics, it gives the distinct impression of being—to quote Doctor Who—“bigger on the inside.” Blazing white, labyrinthine hallways with soaring ceilings (accented with large television monitors displaying high definition photos of different stages of the germination and tissue culture processes) connect to specialized, climate-controlled lab rooms, processing centers, and the plush lounge that serves as the studio for the James Loud Podcast.
The titular host of that podcast, James Loud, is the founder and primary breeder at James Loud Genetics, a cannabis brand with deep roots in the pre-legalization weed game.
Loud cracked his first seed in 1995, at the age of 14, and never looked back. Since then, he’s been exploring the bleeding edge of breeding techniques and technology, always staying true to his name and seeking the same Holy Grail—louder terps.
The son of an engineer, Loud’s process has always been rooted in experimentation and innovation, and in the early days of his breeding career—when police helicopters were still actively scanning for the telltale heat signature of a commercial indoor cannabis grow—he responded with a technological solution.
High Times Magazine, May 2024
“I had a garage grow and we grew in octagons,” Loud says. “So we had vertical growing because we were worried about the footprint for the infrared from the helicopter. So we thought the footprint would be less so the heat signature would be less. And so we grew in these vertical grows where we had 26 plants per light, and they all grew towards that center light.”
With that problem more or less solved, he settled into the business of actually growing cannabis, with varying degrees of success at first.
“I really like Chem Dawg, so I grew some and it was just this wall of larf, it was terrible… outdoor it was phenomenal, indoor it was phenomenal in beds, but it wasn’t meant to be grown in a vertical system with a short veg [period], because it likes to stretch… The best thing for the octagon was GDP because it has a very short veg, so you can take something like GDP and veg it for seven to 10 days max and it still wouldn’t get to the light.”
Loud has made a lifelong career from cannabis breeding, a decision that has taken him on a decades-long personal and professional journey, with stops around the world, from Colombia to Spain and beyond, and it all began in the pages of High Times.
Like many of us who discovered cannabis before the advent of the internet, Loud found information and inspiration in the pages of this very magazine. One year after smoking his first joint at the age of 14, he read something that changed the trajectory of his entire life.
“There was a High Times article when I was younger called ‘The Million-Dollar Grow Room,’ and that was my favorite article growing up… it changed my perspective on growing. We had closet grows and stuff like that, but that article put things in the realm of financial possibility,” he says, then smiles a bit sheepishly and admits, “And I just love High Times.”
One million cannabis seeds.
It’s a sentiment that’s proven to be mutual. James Loud Genetics has secured six High Times Cannabis Cup victories and was inducted into the High Times Seed Bank Hall of Fame in 2014.
“Now I want to do ‘The Billion-Dollar Grow Room, and you can only do that with seeds,” Loud says. “We can make a billion dollars with seeds, no problem.”
Considering the facility’s current production rate of roughly seven million seeds per year, $1 billion in revenue doesn’t seem that farfetched.
His decision to dive headfirst into the risky, unregulated world of clandestine cultivation immediately led him down the path of innovation and experimentation. And once again, High Times played a role in his journey.
“I got the Phototron, you know the ones that were in the back of High Times magazine,” he says with a smile. “The first time we grew, one of my friends fucked it up, he poured a whole gallon of fish emulsion and made the weed taste like salmon.”
But, of course, things got better.
“From the moment I got green bud, I loved the taste, the smells, everything about it including the high,” he says. “I was into all the different flavors, and that’s what’s always motivated my breeding.”
Loud is an experienced cannabis connoisseur, and as a breeder he’s all too familiar with the fickle winds of fashion—this year’s superstar strain is tomorrow’s forgotten fad. So it’s not terribly shocking that he’s a bit of a classicist when it comes to the cultivars he’s passionate about; you’ll often hear him talking about the big names of yesteryear, like Super Silver Haze and Romulan with deep reverence and love.
But there’s one particular cultivar whose haunting siren song still echoes tantalizingly to him from a not so distant past, and his eyes glisten with the light of a secret flame when he speaks her name: Cat Piss.
“That needs to be mentioned in the article, how much I love Cat Piss,” he says. “That’s my desert island strain… it’s super nostalgic, we got it in the ’90s, like mid ’90s.”
James Loud conducts an interview for his podcast.
For Loud, it was the first cultivar he ever smoked that passed what would become one of his go-to tests for gauging just how “loud” some weed is, the re-fire test.
“It’s the first thing that I really remember that you smoked it down to the roach, and you fired it up the next day or even a week later and it still tasted like Cat Piss,” he says.
Younger readers—those of you acclimated to cannabis with the sweet, approachable cake and candy flavors that dominate the current terpene landscape—may not realize that us late 20th century smokers once sought out weed that smelled like animal excretions. Both Skunk and Cat Piss were once towering giants in the minds of stoners seeking the strongest strain, highly prized for the intense intoxicating effects that came along with their raw pungency.
Skunk is undeniably the biggest name that emerged from that era; an amalgamation of three classic landrace cultivars; Acapulco Gold, Colombian Gold, and Afghani, that smelled just like its name. But if Skunk and its direct descendants are like The Beatles and The Rolling Stones—universally acclaimed, widely known, and indelibly linked to the era that produced them—Cat Piss is more like Grand Funk Railroad; equally popular during their shared heyday, but criminally underrated and less widely remembered in the present time.
Loud is setting out to change all that with a project that sits at the intersection of three of his overlapping passions, cannabis breeding, cannabis education, and Cat Piss, a documentary film about his breeding project to resurrect the strain with assistance from the original breeder, which he says will film “this year with a goal of releasing it later in the year.”
During the day of my visit he’s preparing to interview Steve DeAngelo—founder and former CEO of the pioneering cannabis dispensary Harborside—for yet another documentary project collecting the oral history of cannabis. This on top of his recently published book, a groundbreaking textbook on the technical nuances of cannabis breeding and tissue culture, Cannabis Breeding: The Art and Science of Crafting Distinctive Cultivars.
Loud is building a cannabis media empire, and his aspirations are on full display in the slick, professional design of his podcasting studio lounge, which is where the majority of our meeting takes place. It has an elaborate paint job that includes a graffiti-style mural, a large, backlit sign with his logo on it, a wall of Mason jars filled with seeds, a professional array of condenser mics on telescopic stands arranged at a chic wooden conference table surrounded by comfortable office chairs, and a fully stocked bar with everything from Japanese whiskey to cold Imperial ale in the fridge.
The show itself is a fun, informative space where drug war veterans swap stories and give each other their flowers (and/or concentrates) while they’re still alive. The vibe is casual but serious, because everyone involved takes the craft of cannabis cultivation very seriously, but they also tend to be very serious smokers and the James Loud Podcast studio is definitely the smoking section at this facility.
The conversation is wide ranging, often personal, and always entertaining. It’s like Charlie Rose meets Joe Rogan, only instead of asking his guests if they’ve ever smoked DMT, Loud asks them if they’ve ever smoked Cat Piss.
A gen zero tissue culture plant.
At a time when the outlaw past of this industry seems increasingly at odds with the hyper-regulated confines of its present and future, Loud provides a living bridge from past to present and a clear vision for the future.
“We’re slowly but surely becoming tomato farmers,” he says. “The price has gone down. People will be able to make a good living doing it still—obviously there are very successful tomato farmers—but the high prices associated with the black market are mostly long gone.”
The way he sees it, cannabis markets are simply maturing, the way all markets do.
“With mature markets, you see people trusting brands,” he says. “In these unstable markets it’s all about the latest and greatest. I look at it like a Top 40 playlist and there’s not a lot of things that stand the test of time… I think in the future brand trust is going to be a much bigger thing, instead of the latest and greatest thing.”
For Loud, that future is about using meristem tissue culture to secure clean, pathogen-free genetics and following his nose to the next facet of cannabis waiting to be expressed through purposeful breeding.
Guava Gelato Auto
And when it comes to all the new players in the weed game, the ones who never experienced the wild rush of the bad old days of total prohibition? Loud feels like anyone who would subject themselves to the very different challenges of the legal weed game—drug war veteran or not—is a warrior in their own right.
He says his most recent visit to MJBizCon convinced him that the remaining players are all driven by passion, which he believes is the key ingredient to success.
“They aren’t window shopping, they’re really invested in this industry,” he says. “There’s hardship, but the people sticking it out are really passionate about the plant and this is what they’d be doing even if they weren’t getting paid and that’s me, I’m that guy. I’m gonna be breeding no matter what, I’m gonna be smoking no matter what, because this is what I was meant to do.”
This article was originally published in the May 2024 issue of High Times Magazine.
